Innovation Excellence is a unique application of lean kaizen methodologies and personal coaching. It frees up capacity for innovative research, fosters ownership and significantly enhances the output of your research and innovation teams.
Innovation Excellence is a unique application of lean kaizen methodologies and personal coaching. It frees up capacity for innovative research, fosters ownership and significantly enhances the output of your research and innovation teams. It has the goal to improve current work processes in research and development but also life cycle management to increase efficiency. Together with ICH Q8 elements like Quality by Design, Innovation Excellence has to be seen as an overarching paradigm and an interdisciplinary approach across the product development lifecycle. It also systematically emphasises enhanced product throughout the product lifecycle.
Applying a management style that focuses on the process of learning, the art of continuous and scientific research can create a physical as well as a social environment where innovation can flourish.
The Workshop Innovation Excellence , which is also supported by an FDA speaker, will apply continuous improvement tools to help you gain the right knowledge. It will therefore give you a fresh view on how to make your research and development more efficient, faster and customer focused. For that purpose the training is filled with real life examples and exercises on how to:
To provide you the maximum benefit the Workshop is a mix of theoretic foundation and exercises.
For further information please see www.gmp-compliance.org/innovation.
Contact:
European Compliance Academy (ECA)
www.gmp-compliance.orginfo@gmp-compliance.org
Event date: October 30, 2012 - October 31, 2012, Berlin, Germany
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.